Quantcast

Latest autoimmune diseases Stories

2014-03-24 23:03:27

The Autoimmunity Bible And Norton Protocol created by Julia Liu is a newly updated system that teaches people how to treat autoimmune disorders at home. A complete review on the site Vkool.com points out whether or not this program is safe for people to use. Seattle, WA (PRWEB) March 24, 2014 The Autoimmunity Bible And Norton Protocol is the latest e-guide developed by Julia Liu, who promises to help autoimmune diseases treat their condition effectively without using any kind of harmful...

2014-03-24 23:02:53

Five Signature Initiatives Designed to Support 4.6 Million Canadians Living with Arthritis Toronto, Ontario (PRWEB) March 24, 2014 The Arthritis Society today launched a $25 million campaign to engage Canadians in an effort to Erase the Pain of arthritis. As the country’s largest non-governmental funder of arthritis research, The Society is appealing for support in helping the one in six to Canadians that lives directly with arthritis. “Erase the Pain is aimed at bringing real and...

2014-03-21 23:00:27

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Adalimumab Market, 2010-2018” to its store. Dallas, TX (PRWEB) March 22, 2014 Adalimumab is a TNF (tumor necrosis factor) inhibiting antiinflammatory drug, the first fully human monoclonal antibody drug approved by the FDA. It was discovered through collaboration between BASF Bioresearch Corporation and Cambridge Antibody Technology in 1993, then further manufactured at BASF Bioresearch Corporation and...

2014-03-21 12:23:43

- Daily use offers a convenient alternative to bleach baths for management of eczema - DENVER, March 21, 2014 /PRNewswire/ -- A new, independently-conducted study being presented at the 72nd Annual Meeting of the American Academy of Dermatology (AAD) shows that daily use of CLn(®) BodyWash (a novel gel cleanser preserved with sodium hypochlorite) yields significant improvement in pediatric patients with eczema. The study presents 40 subjects from pediatric outpatient dermatology clinics...

2014-03-21 12:22:51

CANTERBURY, England, March 21, 2014 /PRNewswire/ -- - Phase 2b data demonstrates a 60% reduction in pruritus in psoriatic patients treated with CT327 - Data analysis also published in the Journal of the American Academy of Dermatology - Phase 2b CT327 topline data in patients with Atopic Dermatitis and Pruritus due in mid-2014 Creabilis Ltd, the dermatology company with the most advanced targeted topical...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-20 08:29:06

NORTH CHICAGO, Ill., March 20, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. "Since treatment options are limited, we welcome research that evaluates new options for patients suffering...

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...

2014-03-18 16:25:03

Cloud-based training collaboration delivers clinically relevant information anywhere. CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ -- The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and ePharmaSolutions, a leading clinical services and eClinical solutions provider, today announced their partnership to build and deliver online learning courses to clinicians working in psoriasis (PsO) and psoriatic arthritis (PsA) research and development. Via...

2014-03-18 12:31:24

Patients Rapidly Shifting to New Oral Therapies PHILADELPHIA, March 18, 2014 /PRNewswire/ -- Health Union, LLC announced today on its website http://multiplesclerosis.net the topline results from its "2014 MS in America" survey of over 5,000 multiple sclerosis (MS) patients. This survey is one of the largest of its kind ever conducted. Symptoms - Diagnosis - Treatment Gap Even though scientific evidence[i] shows that early treatment can reduce the risk of disease progression,...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.